US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 3.420
  • 0.0000.00%
Close Apr 26 16:00 ET
  • 3.420
  • 0.0000.00%
Post 16:46 ET
279.64MMarket Cap-1921P/E (TTM)

Sutro Biopharma Key Stats

Sutro Biopharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

113.72M

+1217.44%
EPS(YoY)

0.52

+185.25%

Strong Buy

Apr 3, 2024

Sutro Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 20.266M--
--2024/Q1-- / 10.729M--
--2023/Q4113.721M / 13.244M--
--2023/Q316.924M / 13.004M--
--2023/Q210.412M / 12.516M--
--2023/Q112.674M / 12.089M--
--2022/Q48.632M / 14.482M--
--2022/Q325.147M / 35.759M--
--2022/Q228.096M / 13.152M--
--2022/Q15.897M / 10.459M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 20.266M--
--2024/Q1-- / 10.729M--
--2023/Q4113.721M / 13.244M--
--2023/Q316.924M / 13.004M--
--2023/Q210.412M / 12.516M--
--2023/Q112.674M / 12.089M--
--2022/Q48.632M / 14.482M--
--2022/Q325.147M / 35.759M--
--2022/Q228.096M / 13.152M--
--2022/Q15.897M / 10.459M--

Unlock Free Earnings Estimates

Sutro Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 3, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg